SARS-CoV-2 and enhancing antibodies
- PMID: 32438257
- PMCID: PMC7204707
- DOI: 10.1016/j.jcv.2020.104424
SARS-CoV-2 and enhancing antibodies
Comment on
-
Human coronavirus circulation in the United States 2014-2017.J Clin Virol. 2018 Apr;101:52-56. doi: 10.1016/j.jcv.2018.01.019. Epub 2018 Jan 31. J Clin Virol. 2018. PMID: 29427907 Free PMC article.
References
-
- Wang Q., Zhang L., Kuwahara K., Li L., Liu Z., Li T., Zhu H., Liu J., Xu Y., Xie J., Morioka H., Sakaguchi N., Qin C., Liu G. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect. Dis. 2016;2(5):361–376. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous